| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HARP | Harpoon Therapeutics, Inc. | Merck & Co., Inc. | 10% Owner | Mar 11, 2024 | Buy | $23.00 | 21,397,205 | 492,135,715 | 1,000 | Mar 11, 2024, 03:27 PM | |
| HARP | Harpoon Therapeutics, Inc. | HUNT RONALD | Director | Mar 23, 2023 | Buy | $1000.00 | 10,000 | 10,000,000 | 10,000 | Mar 27, 2023, 05:37 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Sep 22, 2021 | Buy | $8.10 | 10,300 | 83,430 | 19,215 | Sep 22, 2021, 09:30 PM | |
| HARP | Harpoon Therapeutics, Inc. | New Leaf BPO Management II, L.L.C | 10% Owner | Jan 11, 2021 | Buy | $17.00 | 235,294 | 3,999,998 | 913,860 | Aug 12, 2021, 04:15 PM | |
| HARP | Harpoon Therapeutics, Inc. | HUNT RONALD | Director | Jan 11, 2021 | Buy | $17.00 | 235,294 | 3,999,998 | 913,860 | Aug 12, 2021, 04:15 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Jul 01, 2021 | Option Exercise | $7.30 | 20,000 | 146,000 | 62,852 | Jul 06, 2021, 06:01 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management LP | 10% Owner | May 28, 2021 | Sale | $21.12 | 13,885 | 293,315 | 6,374,904 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management LP | 10% Owner | Jun 01, 2021 | Sale | $20.44 | 18,491 | 377,956 | 6,353,213 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | Jun 02, 2021 | Sale | $20.50 | 25,118 | 514,919 | 6,328,095 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | May 26, 2021 | Sale | $20.04 | 3,198 | 64,088 | 6,399,550 | May 27, 2021, 07:40 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management LP | 10% Owner | May 27, 2021 | Sale | $20.26 | 13,961 | 282,850 | 6,385,589 | May 27, 2021, 07:40 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | May 21, 2021 | Sale | $20.21 | 10,907 | 220,430 | 6,407,748 | May 24, 2021, 08:11 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 24, 2021 | Sale | $20.12 | 5,000 | 100,600 | 6,402,748 | May 24, 2021, 08:11 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | May 20, 2021 | Sale | $20.34 | 11,713 | 238,242 | 6,418,655 | May 20, 2021, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | May 18, 2021 | Sale | $20.67 | 18,402 | 380,369 | 6,448,201 | May 20, 2021, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 19, 2021 | Sale | $20.39 | 17,833 | 363,615 | 6,430,368 | May 20, 2021, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | May 13, 2021 | Sale | $20.06 | 4,855 | 97,391 | 6,478,169 | May 17, 2021, 05:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 14, 2021 | Sale | $20.04 | 6,900 | 138,276 | 6,471,269 | May 17, 2021, 05:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | May 17, 2021 | Sale | $20.07 | 4,666 | 93,647 | 6,466,603 | May 17, 2021, 05:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | May 05, 2021 | Sale | $22.52 | 10,172 | 229,107 | 6,551,345 | May 06, 2021, 04:05 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | Apr 21, 2021 | Sale | $18.97 | 8,972 | 170,229 | 7,020,675 | Apr 22, 2021, 04:04 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | Apr 16, 2021 | Sale | $19.86 | 5,847 | 116,110 | 7,061,697 | Apr 20, 2021, 06:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 19, 2021 | Sale | $19.30 | 10,056 | 194,059 | 7,051,441 | Apr 20, 2021, 06:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | UBS Oncology Impact Fund L.P. | 10% Owner | Apr 20, 2021 | Sale | $18.71 | 22,249 | 416,382 | 7,029,926 | Apr 20, 2021, 06:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014 GP LLC | Former 10% Owner | Apr 13, 2021 | Sale | $19.46 | 1,943 | 37,806 | 3,223,853 | Apr 15, 2021, 08:01 PM | |
| HARP | Harpoon Therapeutics, Inc. | Foley Todd | Former 10% Owner | Apr 14, 2021 | Sale | $20.77 | 1,671 | 34,714 | 3,223,446 | Apr 15, 2021, 08:01 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014 GP LLC | Former 10% Owner | Apr 15, 2021 | Sale | $20.49 | 1,052 | 21,555 | 3,220,844 | Apr 15, 2021, 08:01 PM | |
| HARP | Harpoon Therapeutics, Inc. | Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | Apr 13, 2021 | Sale | $19.46 | 16,054 | 312,369 | 7,092,108 | Apr 15, 2021, 08:00 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | Apr 14, 2021 | Sale | $20.77 | 13,806 | 286,809 | 7,088,746 | Apr 15, 2021, 08:00 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM Oncology Impact Management GP LLC | 10% Owner | Apr 15, 2021 | Sale | $20.49 | 8,696 | 178,181 | 7,067,244 | Apr 15, 2021, 08:00 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM ASSET MANAGEMENT LLC | 10% Owner | Apr 09, 2021 | Sale | $23.67 | 10,300 | 243,801 | 3,228,006 | Apr 13, 2021, 04:12 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014 (B), L.P. | 10% Owner | Apr 12, 2021 | Sale | $21.02 | 2,496 | 52,460 | 3,226,369 | Apr 13, 2021, 04:12 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Apr 01, 2021 | Sale | $10.52 | 20,000 | 210,491 | 62,852 | Apr 05, 2021, 05:00 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Feb 17, 2021 | Option Exercise | $2.12 | 25,000 | 53,000 | 72,292 | Feb 18, 2021, 08:31 AM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | Feb 10, 2021 | Sale | $20.00 | 183,051 | 3,661,020 | 3,238,306 | Feb 12, 2021, 05:03 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Feb 10, 2021 | Sale | $20.00 | 183,051 | 3,661,020 | 3,238,306 | Feb 12, 2021, 05:03 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | Feb 05, 2021 | Sale | $20.01 | 10,172 | 203,542 | 3,502,885 | Feb 09, 2021, 06:14 PM | |
| HARP | Harpoon Therapeutics, Inc. | Foley Todd | 10% Owner | Feb 08, 2021 | Sale | $20.04 | 72,128 | 1,445,445 | 3,430,757 | Feb 09, 2021, 06:14 PM | |
| HARP | Harpoon Therapeutics, Inc. | Foley Todd | 10% Owner | Feb 09, 2021 | Sale | $20.25 | 9,400 | 190,350 | 3,421,357 | Feb 09, 2021, 06:14 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Feb 04, 2021 | Sale | $20.37 | 29,730 | 605,600 | 3,513,057 | Feb 04, 2021, 07:30 PM | |
| HARP | Harpoon Therapeutics, Inc. | EVNIN LUKE | 10% Owner | Feb 02, 2021 | Sale | $20.13 | 48,421 | 974,715 | 3,584,709 | Feb 04, 2021, 07:30 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM ASSET MANAGEMENT LLC | 10% Owner | Feb 03, 2021 | Sale | $20.21 | 41,922 | 847,244 | 3,542,787 | Feb 04, 2021, 07:30 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM ASSET MANAGEMENT LLC | 10% Owner | Jan 25, 2021 | Sale | $21.23 | 13,006 | 276,117 | 4,341,318 | Jan 27, 2021, 08:35 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Jan 26, 2021 | Sale | $21.08 | 1,363 | 28,732 | 4,339,955 | Jan 27, 2021, 08:35 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | Jan 27, 2021 | Sale | $20.00 | 706,825 | 14,136,500 | 3,633,130 | Jan 27, 2021, 08:35 PM | |
| HARP | Harpoon Therapeutics, Inc. | EVNIN LUKE | 10% Owner | Jan 22, 2021 | Sale | $21.72 | 24,695 | 536,375 | 4,354,324 | Jan 22, 2021, 08:16 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014 LLC | 10% Owner | Jan 20, 2021 | Sale | $24.04 | 17,694 | 425,291 | 4,508,731 | Jan 22, 2021, 08:16 PM | |
| HARP | Harpoon Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | Jan 21, 2021 | Sale | $22.22 | 26,066 | 579,095 | 4,384,106 | Jan 22, 2021, 08:16 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Jan 04, 2021 | Sale | $9.49 | 20,000 | 189,837 | 62,852 | Jan 06, 2021, 06:25 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Oct 01, 2020 | Sale | $8.44 | 20,000 | 168,737 | 62,669 | Oct 05, 2020, 04:25 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Aug 19, 2020 | Buy | $11.40 | 5,000 | 57,000 | 8,915 | Aug 20, 2020, 06:36 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Aug 18, 2020 | Buy | $11.60 | 2,098 | 24,337 | 3,915 | Aug 20, 2020, 06:36 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Jul 31, 2020 | Buy | $10.92 | 1,817 | 19,842 | 1,817 | Aug 04, 2020, 08:32 AM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Jul 01, 2020 | Option Exercise | $8.40 | 20,000 | 167,989 | 62,669 | Jul 02, 2020, 07:18 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience plc | 10% Owner | May 27, 2020 | Sale | $22.39 | 12,064 | 270,144 | 2,560,295 | May 29, 2020, 04:32 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience plc | 10% Owner | May 28, 2020 | Sale | $21.33 | 366,591 | 7,820,926 | 2,193,704 | May 29, 2020, 04:32 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | May 18, 2020 | Sale | $8.44 | 3,044 | 25,705 | 47,276 | May 20, 2020, 06:34 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | May 12, 2020 | Sale | $7.34 | 2,800 | 20,560 | 54,069 | May 13, 2020, 08:45 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | May 07, 2020 | Sale | $7.36 | 10,700 | 78,786 | 58,019 | May 11, 2020, 09:37 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | May 08, 2020 | Sale | $7.30 | 2,000 | 14,600 | 53,669 | May 11, 2020, 09:37 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | May 11, 2020 | Sale | $7.33 | 2,000 | 14,665 | 53,669 | May 11, 2020, 09:37 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | May 01, 2020 | Sale | $7.09 | 11,652 | 82,652 | 51,580 | May 05, 2020, 04:35 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Apr 28, 2020 | Sale | $7.33 | 2,500 | 18,315 | 53,919 | Apr 30, 2020, 04:58 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Apr 16, 2020 | Option Exercise | $7.06 | 1,000 | 7,060 | 46,254 | Apr 17, 2020, 07:10 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Apr 17, 2020 | Option Exercise | $7.10 | 2,042 | 14,495 | 46,775 | Apr 17, 2020, 07:10 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Apr 13, 2020 | Option Exercise | $7.09 | 9,112 | 64,618 | 50,310 | Apr 15, 2020, 04:48 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Apr 06, 2020 | Option Exercise | $7.06 | 1,400 | 9,885 | 46,454 | Apr 08, 2020, 06:10 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Apr 07, 2020 | Option Exercise | $7.06 | 1,140 | 8,048 | 46,324 | Apr 08, 2020, 06:10 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Mar 16, 2020 | Option Exercise | $7.06 | 2 | 14 | 45,755 | Mar 18, 2020, 05:28 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Mar 17, 2020 | Option Exercise | $7.06 | 3,040 | 21,462 | 47,274 | Mar 18, 2020, 05:28 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Mar 02, 2020 | Option Exercise | $8.40 | 11,652 | 97,877 | 51,580 | Mar 03, 2020, 09:31 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Feb 18, 2020 | Option Exercise | $8.56 | 3,042 | 26,040 | 47,275 | Feb 20, 2020, 05:11 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Feb 03, 2020 | Sale | $8.01 | 11,652 | 93,358 | 51,580 | Feb 04, 2020, 08:11 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Jan 21, 2020 | Buy | $14.09 | 6,700 | 94,418 | 6,700 | Jan 23, 2020, 08:34 AM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Jan 16, 2020 | Option Exercise | $8.53 | 3,042 | 25,949 | 47,275 | Jan 21, 2020, 08:05 PM | |
| HARP | Harpoon Therapeutics, Inc. | Wesche Holger | Chief Scientific Officer | Jan 02, 2020 | Option Exercise | $7.50 | 20,000 | 149,987 | 62,669 | Jan 06, 2020, 09:55 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Jan 02, 2020 | Option Exercise | $8.15 | 11,652 | 94,952 | 51,580 | Jan 06, 2020, 09:46 PM | |
| HARP | Harpoon Therapeutics, Inc. | Baeuerle Patrick | Director | Dec 27, 2019 | Sale | $15.98 | 87,379 | 1,396,281 | 273,953 | Dec 30, 2019, 05:32 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Dec 16, 2019 | Sale | $9.57 | 3,042 | 29,112 | 47,275 | Dec 18, 2019, 04:14 PM | |
| HARP | Harpoon Therapeutics, Inc. | Chin Mark | Director | Dec 13, 2019 | Sale | $17.21 | 11,002 | 189,341 | 2,597,915 | Dec 17, 2019, 09:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | Chin Mark | Director | Dec 16, 2019 | Sale | $17.02 | 13,080 | 222,680 | 2,584,835 | Dec 17, 2019, 09:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | Chin Mark | Director | Dec 17, 2019 | Sale | $16.83 | 12,476 | 209,969 | 2,572,359 | Dec 17, 2019, 09:23 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience Holdings Ltd | 10% Owner | Dec 13, 2019 | Sale | $17.21 | 11,002 | 189,341 | 2,597,915 | Dec 17, 2019, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience Holdings Ltd | 10% Owner | Dec 16, 2019 | Sale | $17.02 | 13,080 | 222,680 | 2,584,835 | Dec 17, 2019, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience plc | 10% Owner | Dec 17, 2019 | Sale | $16.83 | 12,476 | 209,969 | 2,572,359 | Dec 17, 2019, 07:20 PM | |
| HARP | Harpoon Therapeutics, Inc. | Chin Mark | Director | Dec 06, 2019 | Sale | $19.15 | 47,752 | 914,222 | 2,844,367 | Dec 10, 2019, 08:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | Chin Mark | Director | Dec 09, 2019 | Sale | $18.16 | 103,754 | 1,884,445 | 2,817,929 | Dec 10, 2019, 08:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | Chin Mark | Director | Dec 10, 2019 | Sale | $16.91 | 131,696 | 2,227,019 | 2,608,917 | Dec 10, 2019, 08:07 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience Holdings Ltd | 10% Owner | Dec 06, 2019 | Sale | $19.15 | 47,752 | 914,222 | 2,844,367 | Dec 10, 2019, 07:27 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience Holdings Ltd | 10% Owner | Dec 09, 2019 | Sale | $18.16 | 103,754 | 1,884,445 | 2,817,929 | Dec 10, 2019, 07:27 PM | |
| HARP | Harpoon Therapeutics, Inc. | Arix Bioscience Holdings Ltd | 10% Owner | Dec 10, 2019 | Sale | $16.91 | 131,696 | 2,227,019 | 2,608,917 | Dec 10, 2019, 07:27 PM | |
| HARP | Harpoon Therapeutics, Inc. | Erbez Georgia | Chief Financial Officer | Dec 04, 2019 | Option Exercise | $2.12 | 47,292 | 100,259 | 47,292 | Dec 06, 2019, 04:41 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Dec 02, 2019 | Sale | $10.05 | 11,652 | 117,103 | 51,580 | Dec 04, 2019, 04:42 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Nov 18, 2019 | Sale | $7.74 | 36,504 | 282,658 | 64,006 | Nov 19, 2019, 04:24 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Nov 01, 2019 | Option Exercise | $7.64 | 11,652 | 89,053 | 51,580 | Nov 05, 2019, 04:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Oct 14, 2019 | Option Exercise | $7.70 | 24,904 | 191,679 | 58,206 | Oct 16, 2019, 05:14 PM | |
| HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | Oct 15, 2019 | Option Exercise | $7.66 | 23,396 | 179,281 | 57,452 | Oct 16, 2019, 05:14 PM | |
| HARP | Harpoon Therapeutics, Inc. | McMahon Gerald PhD | President and CEO | Jun 05, 2019 | Option Exercise | $0.60 | 169,462 | 101,677 | 172,462 | Sep 06, 2019, 07:17 PM | |
| HARP | Harpoon Therapeutics, Inc. | McMahon Gerald PhD | President and CEO | May 14, 2019 | Buy | $10.16 | 1,000 | 10,157 | 3,000 | May 16, 2019, 08:32 AM | |
| HARP | Harpoon Therapeutics, Inc. | McMahon Gerald PhD | President and CEO | May 08, 2019 | Buy | $10.56 | 1,000 | 10,559 | 2,000 | May 10, 2019, 08:31 AM |
Menu